GlassScriptPhysician profile
Jeffrey S Pinto
NPI 1760447379
$11,367.26
in general payments reported to CMS, 2019-2025
36 companies · $2,001 in 2025
The $2,001 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,165 · 2020: $1,432 · 2021: $899 · 2022: $491 · 2023: $1,747 · 2024: $3,632 · 2025: $2,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,217 · Food and Beverage: $2,163.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,217.46 |
| Food and Beverage | $2,163.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $2,814.04 | 2023-2025 | |
| Alphatec Spine, INC | $2,301.39 | 2020-2025 | Other - Miscellaneous |
| Alon Medical Technology | $2,024.36 | 2023-2024 | |
| Arthrex, INC. | $1,726.26 | 2024 | |
| Zimmer Biomet Holdings, INC. | $700.46 | 2019 | |
| Grifols USA, LLC | $229.98 | 2019-2022 | |
| Providence Medical Technology, INC. | $216.01 | 2023-2025 | |
| Boston Scientific Corporation | $147.06 | 2019-2024 | |
| Medtronic, INC. | $103.18 | 2021-2025 | Mazor X System |
| Spinal Simplicity, LLC | $101.54 | 2021 | |
| Highridge Medical LLC | $86.46 | 2024 | Vital |
| Stryker Corporation | $83.49 | 2019-2020 | |
| Depuy Synthes Sales INC. | $80.38 | 2019-2024 | Vivigen Mis Delivery System, Dbx, Fibergraft Aeridyan Matrix |
| Ucb, INC. | $74.22 | 2019-2022 | |
| Neurocrine Biosciences, INC. | $69.98 | 2019-2021 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $68.36 | 2019-2021 | |
| Medtronic USA, INC. | $53.15 | 2019-2020 | |
| Amgen INC. | $52.79 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $50.56 | 2019 | |
| Lundbeck LLC | $48.96 | 2021 | |
| Pacira Therapeutics, INC. | $47.28 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.59 | 2020 | |
| Almatica Pharma LLC | $31.50 | 2021 | |
| Alnylam Pharmaceuticals INC. | $27.58 | 2021 | |
| Globus Medical, INC. | $26.16 | 2023 | Sable |
| Astrazeneca Pharmaceuticals LP | $18.53 | 2025 | Wainua |
| Csl Behring | $18.33 | 2020 | |
| Genentech USA, INC. | $15.79 | 2023 | Ocrevus |
| Pacira Pharmaceuticals Incorporated | $15.58 | 2020 | |
| Kyowa Kirin, INC. | $15.52 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.18 | 2022 | |
| Baudax Bio INC. | $13.01 | 2022 | |
| Assertio Therapeutics, INC. | $12.50 | 2019 | |
| Avanir Pharmaceuticals, INC. | $12.40 | 2022 | |
| Lilly USA, LLC | $12.15 | 2020 | |
| Jazz Pharmaceuticals INC. | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Pinto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.